APGE Stock Analysis: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$134.09
-0.21 (-0.16%)
▼
5d:
-0.14%
30d:
+0.99%
90d:
+61.77%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 10, 2026
7d
Smart Money Distribution
None View Scanner →
Strength: 7.0/10
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: APGE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: APGE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $134.09, which is considered slightly high relative to its 30-day fair value range of $132.94 to $134.23.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$132.94 -
$134.23
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
Protect Your Profits
APGE is technically overbought (RSI 78). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($130.53)
Trading Range Analysis
30-Day Trading Range
$132.94 -
$134.23
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$134.01
Resistance Level
$134.46
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.84
Wall Street Target
$130.53
(-2.7%)
Share & Embed Analysis
Last updated: August 02, 2026 4:54 PM ET
Data refreshes hourly during market hours. Next update: 5:54 PM
Data refreshes hourly during market hours. Next update: 5:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Thomas Henderson
SELL
20000 shares
2026-04-08
Carl Dambkowski
SELL
5500 shares
2026-04-01
Michael Thomas Henderson
SELL
20000 shares
2026-03-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
